Leaders in the Development and Manufacture of Speciality Enzymes
Our Products and Services
Developing #BiobasedValue
The Enzyme Experts – Commercially Intelligent Solutions
Biocatalysts is a biotechnology company with a global reach producing speciality enzymes at commercial scales for a variety of industries. Biocatalysts has used its wide range of technical, commercial and regulatory capabilities to develop #BiobasedValue for our customers.
Resources
View All
29 Oct 2024
Enhancing Enzyme Modified Dairy Ingredients with an Umami Boost
Glutamine is an amino acid found in protein -containing foods. Glutamine can be converted into glutamate and is one of the key factors in contributing a savoury umami taste sensation.
29 Oct 2024
Biocatalysts Ltd Launches Innovative Enzymes Solution to Boost Umami Flavour in Dairy Ingredients
Unique enzyme solution designed to enhance umami flavours in dairy ingredients. This new product combines unique enzyme activities to create rich, savoury profiles to differentiate your dairy ingredients.
1 Oct 2024
BRAIN Biotech AG and Biocatalysts Ltd Launch a New Business Initiative to Revolutionise Enzyme Solutions within the Life Science Industry
Combining cutting-edge enzyme discovery, optimisation, and large-scale manufacturing to offer an end-to-end solution for the life sciences industry. BRAIN-Biocatalysts Life Science Solutions addresses critical gaps in the market, providing tailored enzyme solutions with a transparent IP strategy that ensures partners retain full control over their innovations.
Application Solution
Unlocking the benefits of plant oil hydrolysis
Free fatty acids, the fundamental building blocks in many sectors, can vary in chain length and degree of saturation, influencing their functionality and applications. However, the industry has long faced challenges in maximising the yield of free fatty acids while maintaining cost efficiency and environmental sustainability.
16 Sept 2024
Biocatalysts Ltd Launches Lipomod™ 70MDP - Setting A New Standard To Deliver Sustainable Solutions for Oleochemicals Industry with Maximal Production Efficiency
Achieve superior hydrolysis unseen in the market for breaking down plant-derived oils into valuable by-products like glycerol and fatty acids
30 Aug 2024
BRAIN Biotech AG presents strong cash position with its 9M reporting and is forecasting good sequential growth in the final quarter of the business year
BRAIN Biotech AG, a leading provider of integrated solutions for the biologisation of industry, today published its 9M results of FY2023/2024.
22 Aug 2024
BRAIN Biotech launches MetXtra™
Designed to establish and optimise biocatalytic processes, develop novel enzyme solutions and generate IP or FTO for customers, the cutting edge technologies of MetXtra™ unlock the secrets of the unexplored sequence space.
30 Jul 2024
Biocatalysts Ltd launches new "Plug & Produce" production strains significantly reducing scale-up time and cost
Developing enzyme and protein fermentation processes can be long and expensive and is often reliant on a single partner. Our proprietary "Plug & Produce" platform of microbial fermentation strains can bring product to market quicker, reduce cost and reduce supply chain risk.
23 Jul 2024
The Crucial Role of Phenylalanine Dehydrogenase in Detecting Phenylketonuria
Phenylketonuria (PKU) is genetic disorder resulting from a deficiency in the enzyme phenylalanine hydroxylase for the conversion of the amino acid, phenylalanine to tyrosine. This condition can cause phenylalanine accumulation in the blood and result in neurological damage if left untreated or undiagnosed. Read about the highly specific and sensitive enzymatic method for early detection of PKU.
10 Jun 2024
Enzymes: The Eco-Warriors of Food Manufacturing
As companies increasingly prioritise sustainability, enzymes emerge as unknown heroes, quietly revolutionising the way we produce food.
4 Jun 2024
The Power of Enzymes: Why Hydrolysing Proteins Matters
In the world of biology and biochemistry, the process of hydrolysing proteins using enzymes plays a crucial role in industrial applications, with significant environmental benefits.
30 May 2024
BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets
Parent company BRAIN Biotech AG, a leading provider of integrated solutions for the biologisation of industry, today published its half year results, 6M 2023/2024.
